World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
112
Citations
69945
World Ranking
5051
National Ranking
2735

Michael E. Weinblatt publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael E. Weinblatt sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 568 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael E. Weinblatt D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael E. Weinblatt sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 112 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael E. Weinblatt is affiliated with Brigham and Women's Hospital in the United States. Their research primarily focuses on medicine, with an emphasis on rheumatology. The scientist contributes extensively to fields including infectious diseases, genetics, pathology and forensic medicine, and pulmonary and respiratory medicine.

Their work covers a range of topics related to autoimmune and inflammatory disorders as well as hematologic malignancies. Key research areas include:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Monoclonal and Polyclonal Antibodies Research
  • Autoimmune and Inflammatory Disorders Research

Michael E. Weinblatt has published numerous studies in several frequent publication venues. These include:

  • Annals of the Rheumatic Diseases
  • Arthritis & Rheumatology
  • The Journal of Rheumatology
  • Arthritis Research & Therapy
  • Lara D. Veeken

Some of their recent published papers are:

  • 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis, 2021, Arthritis Care & Research
  • 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis, 2021, Arthritis & Rheumatology
  • American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3, 2020, Arthritis & Rheumatology
  • American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1, 2020, Arthritis & Rheumatology
  • Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease, 2020, The Journal of Rheumatology

Michael E. Weinblatt has worked collaboratively with several co-authors over time, with frequent collaborators including:

  • Nancy A. Shadick
  • Jeffrey A. Sparks
  • Katherine P. Liao
  • Paul F. Dellaripa
  • Daniel H. Solomon

Best Publications

  • Principal components analysis corrects for stratification in genome-wide association studies

    Alkes L Price;Alkes L Price;Nick J Patterson;Robert M Plenge;Robert M Plenge;Michael E Weinblatt

  • American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

    David T. Felson;David T. Felson;Jennifer J. Anderson;Jennifer J. Anderson;Maarten Boers;Claire Bombardier;Claire Bombardier

  • A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

    Michael E. Weinblatt;Joel M. Kremer;Arthur D. Bankhurst;Ken J. Bulpitt

  • The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

    Felson Dt;Anderson Jj;Boers M;Bombardier C

  • Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

    Michael E. Weinblatt;Edward C. Keystone;Daniel E. Furst;Larry W. Moreland

  • Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial

    Larry W. Moreland;Michael H. Schiff;Scott W. Baumgartner;Elizabeth A. Tindall

  • The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.

    Shixin Qin;James B. Rottman;Paul Myers;Nasim Kassam

  • Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

    Eli A Stahl;Soumya Raychaudhuri;Soumya Raychaudhuri;Elaine F Remmers;Gang Xie

  • Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production

    Eric Boilard;Peter A. Nigrovic;Peter A. Nigrovic;Katherine Larabee;Gerald F. M. Watts

  • Efficacy of low-dose methotrexate in rheumatoid arthritis.

    Michael E. Weinblatt;Jonathan S. Coblyn;David A. Fox;Patricia A. Fraser

  • 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Liana Fraenkel;Joan M Bathon;Bryant R England;E William St Clair

  • Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis

    Deepak A. Rao;Michael F. Gurish;Jennifer L. Marshall;Kamil Slowikowski

  • Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.

    Stanley Cohen;Eric Hurd;John Cush;Michael Schiff

  • Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

    Peter C. Taylor;Edward C. Keystone;Désirée van der Heijde;Michael E. Weinblatt

  • Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology

    J M Kremer;G S Alarcón;R W Lightfoot;R F Willkens

  • Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

    Christopher P Cannon;Sean P Curtis;Garret A FitzGerald;Henry Krum

  • Two independent alleles at 6q23 associated with risk of rheumatoid arthritis

    Robert M Plenge;Robert M Plenge;Robert M Plenge;Chris Cotsapas;Chris Cotsapas;Leela Davies;Alkes L Price;Alkes L Price

  • Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

    D. Aletaha;R.B. Landewe;T. Karonitsch;J. Bathon

  • Common variants at CD40 and other loci confer risk of rheumatoid arthritis

    Soumya Raychaudhuri;Soumya Raychaudhuri;Soumya Raychaudhuri;Elaine F Remmers;Annette T Lee;Rachel Hackett

  • Etanercept Therapy in Rheumatoid Arthritis

    Larry W. Moreland;Michael H. Schiff;Scott W. Baumgartner;Elizabeth A. Tindall

Frequent Co-Authors

Daniel H. Solomon
Daniel H. Solomon Brigham and Women's Hospital
Roy Fleischmann
Roy Fleischmann The University of Texas Southwestern Medical Center
Mark C. Genovese
Mark C. Genovese Stanford University
Paul Emery
Paul Emery University of Leeds
Clifton O. Bingham
Clifton O. Bingham Johns Hopkins University
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Joel M. Kremer
Joel M. Kremer Albany Medical Center Hospital
Robert M. Plenge
Robert M. Plenge Bristol Myers Squibb
Edward C. Keystone
Edward C. Keystone University of Toronto
Elizabeth W. Karlson
Elizabeth W. Karlson Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative or flexible pathways, a range of related online degrees are available. Some of the online direct entry MSN programs let non-nurses make a fast career transition into advanced nursing, with options designed to let you qualify quickly if you already hold a bachelor’s degree in another field.

If you’re starting without prior nursing experience, online BSN programs for non nurses also offer flexible entry points. These programs help students earn their Bachelor of Science in Nursing and start a rewarding healthcare career with minimal prerequisites.

Not all medical careers require direct patient care. For example, studying online medical billing and coding with financial aid can lead to in-demand careers that support hospitals and clinics from an administrative perspective.

Plus, if you’re concerned about entry exams, you may be relieved to know that do all nursing schools require the teas explores alternative nursing schools that waive entrance tests, making the admission process less stressful.

Best Scientists Citing Michael E. Weinblatt

Trending Scientists

Recently Published Articles